If the FDA follows an advisory committee’s vote, it can potentially be a transformative step in the delivery of mental health ...

A machine learning model trained on electronic health record (EHR) data predicted progression to schizophrenia or bipolar ...

FDA convened a joint meeting of its Drug Safety and Risk Management Advisory Committee and the Psychopharmacologic Drugs ...

Long-acting injectables are transforming schizophrenia treatment by ensuring medication adherence and reducing relapse rates.

During acute episodes, patients may experience psychotic symptoms that impair their ability to control thoughts, emotions and ...

Now, new research from the Warren Center for Neuroscience Drug Discovery (WCNDD) offers hope. Scientists have identified a ...

A new cohort study found that schizophrenia cases related to cannabis use disorder serious enough to warrant a person to seek emergency care increased afte ...

In this review the terms psychosocial interventions and psychosocial treatment are used interchangeably to refer to nonpharmacologic interventions designed to decrease symptom severity or distress ...

CBD has shown promise as a treatment for psychosis in small studies and case reports. A large, international trial launching ...

A new study has found that individuals who visit emergency departments (ED) due to hallucinogen use have a significantly higher risk of developing schizophrenia. The research, conducted by scientists ...

A comprehensive analysis has identified novel enhancers associated with neuronal development and disease.